In these two models, insulin/Akt signaling hyperactivation results, in part, from compensatory hyperinsulinemia and promotes early adaptive cardiac response and a metabolic switch from fatty acid oxidation to glycolytic way (Riehle & Abel, 2016). The gene discussed is AKT1; the disease is hyperinsulinism.